(Q34838240)

4 August 2017

1 reference

title

Use of complement inhibitors in tissue injury (English)

1 reference

4 August 2017

Richard J Quigg

1

1 reference

4 August 2017

1 September 2002

1 reference

Trends in Molecular Medicine

4 August 2017

1 reference

4 August 2017

8

1 reference

4 August 2017

9

1 reference

4 August 2017

430-436

1 reference

Complement. First of two parts

4 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902386-9

7 January 2021

Membrane signaling by complement C5b-9, the membrane attack complex

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902386-9

7 January 2021

Control of the complement system.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902386-9

7 January 2021

Structure, organization, and regulation of the complement genes

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902386-9

7 January 2021

Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902386-9

7 January 2021

Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902386-9

7 January 2021

Membrane-targeted complement inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902386-9

7 January 2021

Recombinant glycoproteins that inhibit complement activation and also bind the selectin adhesion molecules

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902386-9

7 January 2021

Therapeutic efficacy of a novel membrane-targeted complement regulator in antigen-induced arthritis in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902386-9

7 January 2021

Inhibition of complement activity by humanized anti-C5 antibody and single-chain Fv.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902386-9

7 January 2021

C1-inhibitor: an anti-inflammatory reagent with therapeutic potential

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902386-9

7 January 2021

Production and functional analysis of rat CD59 and chimeric CD59-Crry as active soluble proteins in Pichia pastoris

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902386-9

7 January 2021

Derivation of RNA aptamer inhibitors of human complement C5.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902386-9

7 January 2021

Serine proteases of the complement system

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902386-9

7 January 2021

Complement inhibitors: a resurgent concept in anti-inflammatory therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902386-9

7 January 2021

Targeting complement in therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902386-9

7 January 2021

Therapeutic uses of recombinant complement receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902386-9

7 January 2021

Neuronal protection in stroke by an sLex-glycosylated complement inhibitory protein.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902386-9

7 January 2021

Mouse Crry/p65 is a regulator of the alternative pathway of complement activation

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902386-9

7 January 2021

Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902386-9

7 January 2021

Transgenic mice overexpressing the complement inhibitor crry as a soluble protein are protected from antibody-induced glomerular injury

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902386-9

7 January 2021

Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902386-9

7 January 2021

Transgenic expression of a soluble complement inhibitor protects against renal disease and promotes survival in MRL/lpr mice

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902386-9

7 January 2021

Anti-C5 monoclonal antibody therapy prevents collagen-induced arthritis and ameliorates established disease

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902386-9

7 January 2021

Amelioration of lupus-like autoimmune disease in NZB/WF1 mice after treatment with a blocking monoclonal antibody specific for complement component C5.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902386-9

7 January 2021

Phase I trial of the recombinant soluble complement receptor 1 in acute lung injury and acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902386-9

7 January 2021

Complement activation in synovial fluid and tissue from patients with juvenile rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902386-9

7 January 2021

Complement activation in patients with rheumatoid arthritis mediated in part by C-reactive protein

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902386-9

7 January 2021

Complement-induced glomerular epithelial cell injury. Role of the membrane attack complex in rat membranous nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902386-9

7 January 2021

Physiological and pathological aspects of circulating immune complexes

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902386-9

7 January 2021

The Clearance of Immune Complexes From the Circulation of Man and Other Primates

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902386-9

7 January 2021

Role of complement in induction of antibody production in vivo. Effect of cobra factor and other C3-reactive agents on thymus-dependent and thymus-independent antibody responses

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902386-9

7 January 2021

The role of complement and complement receptors in induction and regulation of immunity.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902386-9

7 January 2021

Complement deficiency and autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902386-9

7 January 2021

Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902386-9

7 January 2021

Immune complex glomerulonephritis in C4- and C3-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902386-9

7 January 2021

A critical role for complement in maintenance of self-tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902386-9

7 January 2021

Inherited deficiency of C8 in a patient with recurrent meningococcal infections: Further evidence for a dysfunctional C8 molecule and nonlinkage to the HLA system

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902386-9

7 January 2021

Infectious diseases associated with complement deficiencies

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902386-9

7 January 2021

Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902386-9

7 January 2021

10.1016/S1471-4914(02)02386-9

Identifiers

DOI

1 reference

4 August 2017

1 reference

PubMed ID

12223314